Business
Teva says that the move is designed to reduce its finance costs.
Hi, what are you looking for?
Teva says that the move is designed to reduce its finance costs.
The former president and CEO Teva Americas Generics earned $7.3 million in 2014.
Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that the first person has been...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the...
– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. – The US Supreme...
Medpro Pharrmaceutica, a subsidiary company of Cipla Medpro, the third largest pharmaceutical company in South Africa, has entered into a collaboration with Teva Pharmaceuticals,...
– Teva confirmed that it will continue to vigorously defend its Copaxone intellectual property rights. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
– According to a recent SEC filing, reported by Economic Policy Journal, the largest stake held by the George Soros Fund Management is a...
– Soros has once again succeeded in raising a few eyebrows on the international market by increasing his holdings in under pressure pharmaceutical giants...
– Levin announced that will be leaving his post as head of UBM, the international events organizers in 2014. – David Levin / Getty...